Joint Corp income statement
In fiscal 2025, Joint Corp reported revenue of $54.9m, up 5.2% on the year before, operating income of −$913,376 (a -1.7% margin) and net income of $2.9m, or $0.19 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 7 | 14 | 21 | 25 | 37 | 48 | 59 | 80 | 101 | 118 | 52 | 55 | 59 |
| Cost of revenue | 2 | 2 | 3 | 3 | 3 | 4 | 6 | 7 | 8 | 12 | 10 | 12 | 11 | 11 |
| Gross profit | 4 | 5 | 11 | 18 | 22 | 32 | 43 | 52 | 72 | 90 | 107 | 41 | 44 | 48 |
| Selling, general and administrative | 4 | 6 | 20 | 29 | 25 | 32 | 39 | 47 | 66 | 42 | 36 | 42 | 45 | 46 |
| Operating income | 0 | −2 | −9 | −15 | −3 | 0 | 3 | 5 | 6 | −2 | 0 | −2 | −1 | 1 |
| Income before tax | 0 | −2 | −9 | −15 | −3 | 0 | 3 | 5 | 6 | −2 | 0 | −2 | −0 | 2 |
| Income tax | 0 | 1 | −0 | 0 | 0 | −0 | 0 | −8 | −2 | 0 | 11 | 0 | 0 | 0 |
| Net income | 0 | −3 | −9 | −15 | −3 | 0 | 3 | 13 | 8 | 1 | −10 | −6 | 3 | 4 |
| Diluted EPS | $0.02 | −$0.56 | −$0.88 | −$1.20 | −$0.26 | $0.01 | $0.23 | $0.90 | $0.51 | −$0.38 | −$0.65 | −$0.38 | $0.19 | $0.26 |
| Diluted shares (average) | 7m | 5m | 10m | 13m | 13m | 14m | 14m | 15m | 15m | 15m | 15m | 15m | 15m | 15m |
| EBITDA | 1 | −1 | −8 | −12 | −1 | 2 | 5 | 8 | 10 | 5 | 9 | 3 | 1 | 3 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 30 | 15 | 13 | 13 | 13 | 15 | 15 | 15 |
| Cost of revenue | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Gross profit | 27 | 12 | 10 | 10 | 11 | 12 | 12 | 13 |
| Selling, general and administrative | 10 | 11 | 11 | 12 | 11 | 12 | 11 | 13 |
| Operating income | −0 | 1 | −1 | −1 | 0 | 1 | 1 | −0 |
| Income before tax | −0 | 1 | −0 | −1 | 0 | 1 | 1 | −0 |
| Income tax | 0 | −0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −3 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Diluted EPS | −$0.03 | $0.00 | $0.06 | $0.01 | $0.06 | $0.07 | $0.09 | $0.05 |
| EBITDA | 1 | 1 | −0 | −1 | 1 | 1 | 1 | 0 |
Compare with peers
- Haoxi Health Technology Ltd income statement
- Cryo Cell International Inc income statement
- American Shared Hospital Services income statement
- Ridgetech Inc. income statement
- NRC Health income statement
Head to head: HAO vs JYNTCCEL vs JYNTAMS vs JYNT
More: Health Care Services stocks compared, Health Care sector, rankings of US companies